A study conducted using human hepatoma cells revealed that low concentrations of arecoline induced cell proliferation and migration by activating the PI3K/Akt/mammalian target of rapamycin (mTOR) pathway [68]; unfortunately, these findings were not validated in studies using human, animal, or cellular models. This evidence concerns the gene MTOR and hepatocellular carcinoma.